Robert Matthew Lutz

Insider

First SEC filing: Feb. 14, 2025 · Latest: Feb. 14, 2025

On this page

Insider at

0 buys (P) 0 sells (S) Net: $0 + 15 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

15 other filings hidden

Date	Ticker	Code	Shares	Price	Value	Owned after	Δ own	A/D	vs now
July 15, 2026	SVRA	A	70,000	—	—	70,000 Direct	—	Acquired	(price as of 2026-08-20)
July 15, 2026	SVRA	A	35,000	—	—	328,977 Direct	+11.91%	Acquired	(price as of 2026-08-20)
Dec. 14, 2025	SVRA	F	67,760	$6.92	$468,899	293,977 Direct	-18.73%	Disposed	-19.9% (price as of 2026-08-20)
Feb. 13, 2025	SVRA	F	38,263	$2.83	$108,284	361,737 Direct	-9.57%	Disposed	95.9% (price as of 2026-08-20)
Dec. 12, 2024	SVRA	A	300,000	—	—	300,000 Direct	—	Acquired	(price as of 2026-08-20)
Dec. 12, 2024	SVRA	A	100,000	—	—	400,000 Direct	+33.33%	Acquired	(price as of 2026-08-20)
Dec. 14, 2023	SVRA	A	40,000	—	—	40,000 Direct	—	Acquired	(price as of 2026-08-20)
Dec. 14, 2023	SVRA	A	160,000	—	—	300,000 Direct	+114.29%	Acquired	(price as of 2026-08-20)
Feb. 24, 2023	SVRA	A	350,000	—	—	350,000 Direct	—	Acquired	(price as of 2026-08-20)
Feb. 24, 2023	SVRA	A	140,000	—	—	140,000 Direct	—	Acquired	(price as of 2026-08-20)
Nov. 11, 2022	IBIO	A	100,057	—	—	102,165 Direct	+4746.54%	Acquired	(price as of 2026-08-20)
Aug. 29, 2022	IBIO	A	400,000	—	—	400,000 Direct	—	Acquired	(price as of 2026-08-20)
March 10, 2022	IBIO	S	24,625	$0.35	$8,619	207,375 Direct	-10.61%	Disposed	-99.2% (price as of 2026-08-20)
Aug. 23, 2021	IBIO	A	500,000	—	—	500,000 Direct	—	Acquired	(price as of 2026-08-20)
March 4, 2021	IBIO	A	350,000	—	—	350,000 Direct	—	Acquired	(price as of 2026-08-20)
March 4, 2021	IBIO	A	232,000	—	—	232,000 Direct	—	Acquired	(price as of 2026-08-20)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Options, RSUs and convertible securities reported on Form 4 Table II.

Date	Ticker	Security	Underlying	Exercise price	Expiration	Shares	A/D
July 15, 2026	SVRA	Stock Option (Right to Buy)	Common Stock (70,000)	$5.81	July 15, 2036	70,000	Acquired
Dec. 12, 2024	SVRA	Stock Option (Right to Buy)	Common Stock (300,000)	$3.35	Dec. 12, 2034	300,000	Acquired
Dec. 14, 2023	SVRA	Stock Option (Right to Buy)	Common Stock (40,000)	$4.45	Dec. 14, 2033	40,000	Acquired
Feb. 24, 2023	SVRA	Stock Option (Right to Buy)	Common Stock (350,000)	$2.53	Feb. 24, 2033	350,000	Acquired
Aug. 29, 2022	IBIO	Stock Option (right to buy) [F1]	Common Stock (400,000)	$0.28	Aug. 28, 2032	400,000	Acquired
Aug. 23, 2021	IBIO	Stock Option (right to buy) [F1]	Common Stock (500,000)	$1.26	Aug. 22, 2031	500,000	Acquired
March 4, 2021	IBIO	Stock Option (right to buy)	Common Stock (350,000)	$1.43	March 4, 2031	350,000	Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Matched by name from proxy statements (DEF 14A) — verify against the filing.

Fiscal year	Salary	Bonus	Stock awards	Option awards	Non-equity incentive	Pension change	Other	Total
2025	$471,000	—	—	—	$176,625	—	$18,000	$2,278,125
2024	$454,480	$18,179	—	$864,337	$181,792	—	$18,000	$1,871,788
2023	$387,341	$143,405	—	$874,534	$174,800	—	$18,000	$2,664,280

Fiscal year	Salary	Bonus	Stock awards	Option awards	Non-equity incentive	Pension change	Other	Total
2022	$425,000	—	—	—	—	—	—	$1,157,922

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.